PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-233

  1. 9,808 Posts.
    lightbulb Created with Sketch. 1243
    My view is continuous disclosure rules are at play and they can't say too much more than already presented at AGM (Beverley) until its legally binding.

    If they have reached substantive agreement on the terms of a material transaction but which have not yet signed legally binding documentation PAR should be especially vigilant in monitoring the market and the media for signs that information about the transaction may have leaked.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.